Epigenetics and pancreatic cancer: Pathophysiology and novel treatment aspects

doi:10.3748/wjg.v20.i24.7830

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 24

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (16819)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-6) series.

Item

Count

PDF

1045

WORD

366

HTML

12490

Figures (1-1)

298

Tables (1-6)

482

Sum=14681

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1156

Download

982

Sum=2138

Jun 28, 2014 (publication date) through Nov 18, 2024

Times Cited of This Article

Times Cited (73)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Jun 28, 2014; 20(24): 7830-7848
Published online Jun 28, 2014. doi: 10.3748/wjg.v20.i24.7830

Open in New Tab Full Size Figure Download Figure

Figure 1 Precursor lesions of pancreatic cancer with their typical morphologic and genetic as well epigenetic characteristics. PanIN: Pancreatic intraepithelial lesions; IPMN: Intraductal papillary mucinous neoplasms; MCN: Mucinous cystic neoplasms; RELN: Reelin.

Citation: Neureiter D, Jäger T, Ocker M, Kiesslich T. Epigenetics and pancreatic cancer: Pathophysiology and novel treatment aspects. World J Gastroenterol 2014; 20(24): 7830-7848
URL: https://www.wjgnet.com/1007-9327/full/v20/i24/7830.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i24.7830